Rawlins Michael 4
4 · Intra-Cellular Therapies, Inc. · Filed Jun 13, 2022
Insider Transaction Report
Form 4
Rawlins Michael
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-09+16,757→ 16,757 totalExercise: $55.48From: 2023-06-09Exp: 2032-06-08→ Common Stock (16,757 underlying)